It may be worth checking. Internist Paul Tang, vice president and chief medical information officer of the multispecialty group practice Palo Alto (Calif.) Medical Foundation, says he's seen contracts from electronic and personal health-record vendors that obligate physicians to violate the federal health-care privacy rules under the Health Insurance Portability and Accountability Act.
It may be worth checking. Internist Paul Tang, vice president and chief medical information officer of the multispecialty group practice Palo Alto (Calif.) Medical Foundation, says he's seen contracts from electronic and personal health-record vendors that obligate physicians to violate the federal health-care privacy rules under the Health Insurance Portability and Accountability Act.
While such language is not the standard, Tang told Modern Healthcare (7/23/2007), "There are contracts that say they (the vendors) will have real-time access to the database, that they will have exclusive access to the data, that they can resell the data. I think it would be unlawful that covered entities abide by that."
Robert Gellman, an attorney specializing in privacy issues, agrees: "Any contract that deals with ownership of medical data is pretty meaningless, because laws and medical ethics control the rights and responsibilities of medical records."
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More